Weiwei Yan

881 total citations
34 papers, 613 citations indexed

About

Weiwei Yan is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weiwei Yan has authored 34 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weiwei Yan's work include Lung Cancer Treatments and Mutations (7 papers), Cancer-related gene regulation (5 papers) and Lung Cancer Research Studies (5 papers). Weiwei Yan is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer-related gene regulation (5 papers) and Lung Cancer Research Studies (5 papers). Weiwei Yan collaborates with scholars based in China, United States and Italy. Weiwei Yan's co-authors include Hui Zhu, Jinming Yu, Yiping Wang, Qun‐Ying Lei, Ji‐Bin Peng, Xiaoming Bao, Yingying Xu, Liming Wei, Miao Yin and Xingyu Zhong and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Plant Cell.

In The Last Decade

Weiwei Yan

29 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Yan China 14 281 142 136 100 66 34 613
Lawrence Lansing United States 7 397 1.4× 135 1.0× 38 0.3× 77 0.8× 56 0.8× 10 886
Yuqin Sun China 15 227 0.8× 56 0.4× 76 0.6× 91 0.9× 62 0.9× 45 550
H Zhang China 11 325 1.2× 81 0.6× 33 0.2× 130 1.3× 54 0.8× 26 563
Jinqing Li China 18 424 1.5× 129 0.9× 105 0.8× 57 0.6× 58 0.9× 39 861
Qing Sun China 13 284 1.0× 58 0.4× 73 0.5× 89 0.9× 141 2.1× 31 601
Joel J. Bergh United States 10 440 1.6× 111 0.8× 31 0.2× 67 0.7× 39 0.6× 11 877
Guojun Wei China 16 240 0.9× 67 0.5× 43 0.3× 81 0.8× 36 0.5× 39 570

Countries citing papers authored by Weiwei Yan

Since Specialization
Citations

This map shows the geographic impact of Weiwei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Yan more than expected).

Fields of papers citing papers by Weiwei Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Yan. The network helps show where Weiwei Yan may publish in the future.

Co-authorship network of co-authors of Weiwei Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Yan. A scholar is included among the top collaborators of Weiwei Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Yan. Weiwei Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Yan, Weiwei, et al.. (2025). Cancer-associated fibroblast-derived fibulin-5 promotes radioresistance in non-small-cell lung cancer. Cell Reports. 44(8). 116018–116018. 2 indexed citations
4.
Xia, Di, et al.. (2024). Targeting inhibition of TCTP could inhibit proliferation and induce apoptosis in AML cells. Cellular Signalling. 117. 111074–111074.
5.
Yan, Weiwei, et al.. (2024). Progressive Disease with Mixed Response After Immunotherapy in Non-Small Cell Lung Cancer. Journal of Inflammation Research. Volume 17. 6317–6327.
6.
Yan, Weiwei, Yang Liu, Jiahui Chen, et al.. (2024). PRMT5-mediated FUBP1 methylation accelerates prostate cancer progression. Journal of Clinical Investigation. 134(18). 5 indexed citations
7.
8.
Yan, Weiwei, Xi Chen, Vivek Verma, et al.. (2024). Potential Role of Lymphocyte CD44 in Determining Treatment Selection Between Stereotactic Body Radiation Therapy and Surgery for Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(1). 89–101. 1 indexed citations
9.
Yan, Weiwei, Qi Wang, Jing Huang, et al.. (2024). A postoperative tumor-specific death prediction model for patients with endometrial cancer: a retrospective study. Translational Cancer Research. 13(2). 1083–1090.
10.
Huang, Shengsong, Weiwei Yan, Qian Zhuang, et al.. (2023). Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer. Journal of Clinical Investigation. 133(24). 22 indexed citations
11.
Dai, Guo‐Zheng, Haifeng Xu, Zhengke Li, et al.. (2023). Hypothetical chloroplast reading frame 51 encodes a photosystem I assembly factor in cyanobacteria. The Plant Cell. 36(5). 1844–1867. 6 indexed citations
12.
Yan, Weiwei, et al.. (2021). Febuxostat Inhibits MPP+-Induced Inflammatory Response Through Inhibiting the JNK/NF-κB Pathway in Astrocytes. Neurotoxicity Research. 39(3). 566–574. 6 indexed citations
13.
14.
Liu, Chao, Jing Wang, Ning An, et al.. (2019). Prognostic significance of peripheral CD8+CD28+ and CD8+CD28− T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy. Journal of Translational Medicine. 17(1). 344–344. 24 indexed citations
15.
Wang, Jing, et al.. (2019). Slight advantages of nimotuzumab versus cetuximab plus concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. Cancer Biology & Therapy. 20(8). 1121–1126. 16 indexed citations
16.
Huang, Yan, Wanjin Li, Weiwei Yan, et al.. (2019). Loss of PICH promotes chromosome instability and cell death in triple-negative breast cancer. Cell Death and Disease. 10(6). 428–428. 24 indexed citations
17.
Yan, Weiwei, Zhenyu Zhu, Fei Pan, Ang Huang, & Guanghai Dai. (2018). Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma. OncoTargets and Therapy. Volume 11. 1285–1292. 12 indexed citations
18.
Yan, Weiwei, Qixiang Zhang, Di Wang, et al.. (2018). Arginine methylation of SIRT 7 couples glucose sensing with mitochondria biogenesis. EMBO Reports. 19(12). 72 indexed citations
19.
Zhong, Xingyu, Yingying Xu, Miao Yin, et al.. (2018). CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer. Cell Reports. 24(12). 3207–3223. 119 indexed citations
20.
Yan, Weiwei, et al.. (2016). Effect of antidepressants on spatial memory deficit induced by dizocilpine. Psychiatry Research. 244. 266–272. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lawrence Lansing Breakdown of academic impact, for papers by Yuqin Sun Breakdown of academic impact, for papers by H Zhang Breakdown of academic impact, for papers by Jinqing Li Breakdown of academic impact, for papers by Qing Sun Breakdown of academic impact, for papers by Joel J. Bergh Breakdown of academic impact, for papers by Guojun Wei
Rankless by CCL
2026